Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial membrane and thiol-rich proteins represent a broad set of targets for non-specific antimicrobial agents, most notably heavy metal-based compounds like silver and mercury [1]. These targets encompass a variety of essential bacterial and fungal components, including transmembrane transporters, respiratory enzymes, and structural proteins that contain reactive cysteine residues with sulfhydryl (thiol) groups [2]. The interaction typically involves the binding of metal cations (such as silver ions) to these thiol groups, which results in the denaturation of proteins, loss of enzymatic activity, and the compromise of membrane integrity [3]. This disruption leads to the leakage of intracellular contents, inhibition of DNA replication, and the eventual death of the microorganism [2]. Because these targets are fundamental to microbial physiology and are present across many species, agents acting on them are often effective against a broad array of pathogens, including multi-drug resistant strains [1]. However, the non-specific nature of these interactions can pose challenges regarding host cell toxicity, such as interference with human wound healing processes [3]. Sources: [1] DrugBank Online, Silver Sulfadiazine (DB01015); [2] Frontiers in Microbiology, Antimicrobial Mechanisms of Silver (2018); [3] PubChem, Silver Nitrate Compound Summary.
Covalent binding to thiol (sulfhydryl) groups causing protein denaturation, enzymatic inhibition, and microbial membrane leakage.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial membrane and thiol-rich proteins.